A detailed history of Hudson Value Partners, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Hudson Value Partners, LLC holds 9,983 shares of PFE stock, worth $265,148. This represents 0.12% of its overall portfolio holdings.

Number of Shares
9,983
Previous 10,201 2.14%
Holding current value
$265,148
Previous $285,000 1.05%
% of portfolio
0.12%
Previous 0.12%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$27.7 - $31.39 $6,038 - $6,843
-218 Reduced 2.14%
9,983 $288,000
Q1 2024

May 08, 2024

SELL
$25.89 - $29.73 $42,847 - $49,203
-1,655 Reduced 13.96%
10,201 $283,000
Q4 2023

Feb 09, 2024

SELL
$26.13 - $33.94 $156,205 - $202,893
-5,978 Reduced 33.52%
11,856 $341,000
Q2 2023

Aug 02, 2023

SELL
$36.12 - $41.79 $3,720 - $4,304
-103 Reduced 0.57%
17,834 $654,000
Q1 2023

May 09, 2023

BUY
$39.39 - $51.28 $27,691 - $36,049
703 Added 4.08%
17,937 $731,000
Q4 2022

Jan 27, 2023

SELL
$41.75 - $54.5 $12,566 - $16,404
-301 Reduced 1.72%
17,234 $883,000
Q2 2022

Jul 29, 2022

SELL
$46.53 - $55.17 $91,664 - $108,684
-1,970 Reduced 10.1%
17,535 $919,000
Q1 2022

Apr 14, 2022

BUY
$45.75 - $56.69 $1,098 - $1,360
24 Added 0.12%
19,505 $1.01 Million
Q3 2021

Oct 29, 2021

BUY
$39.25 - $50.42 $11,775 - $15,126
300 Added 1.56%
19,481 $838,000
Q2 2021

Jul 09, 2021

BUY
$35.91 - $40.68 $6,248 - $7,078
174 Added 0.92%
19,181 $751,000
Q1 2021

Apr 19, 2021

SELL
$33.49 - $37.77 $33,490 - $37,770
-1,000 Reduced 5.0%
19,007 $689,000
Q4 2020

Feb 18, 2021

BUY
$33.47 - $42.56 $669,634 - $851,497
20,007 New
20,007 $735,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $149B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Hudson Value Partners, LLC Portfolio

Follow Hudson Value Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Value Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hudson Value Partners, LLC with notifications on news.